title: [Ciprofloxacin in the treatment of bronchopulmonary infections].
abstract: Ciprofloxacin was given orally in dosages of 250 mg or 500 mg every 12 hours for a period of 8-13 days. Most patients had chronic bronchitis in the acute stage. The favourable results achieved and the complete absence of side effects show that ciprofloxacin is a useful drug in the treatment of respiratory tract infections.
authors.affiliation: Istituto di Clinica Tisiologica, Malattie Respiratorie e Fisiopatologia Respiratoria Università degli Studi di Messina.
authors.forename: G
authors.initials: G
authors.lastname: Girbino
authors.forename: G
authors.initials: G
authors.lastname: Giacobbe
authors.forename: G
authors.initials: G
authors.lastname: Quattrone
authors.forename: G
authors.initials: G
authors.lastname: Fiorello
mesh_terms: D000328:Adult; D001991:Bronchitis / Q000188:drug therapy; D002908:Chronic Disease; D002939:Ciprofloxacin / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D012141:Respiratory Tract Infections / Q000188:drug therapy* / Q000382:microbiology
chemical_list: D002939:Ciprofloxacin
vernacular_title: Ciprofloxacin nel trattamento delle infezioni broncopolmonari.